Targeting the Mevalonate Pathway for Treating Esophageal Cancer
ConclusionThere is a growing body of literature that has shown the anti-cancer properties of statins in the setting of various malignancies. Herein, we summarize the current literature as it pertains to how the mevalonate pathway can be targeted by statins for potentially treating esophageal cancer.
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Cholesterol | Esophagus Cancer | Gastroenterology | Statin Therapy | Study